Flecainide/Modafinil - Theranexus

Drug Profile

Flecainide/Modafinil - Theranexus

Alternative Names: Modafinil/flecainide - Theranexus; THN-102

Latest Information Update: 10 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Theranexus
  • Class Benzhydryl compounds; Class Ic antiarrhythmics; Piperidines; Sleep disorder therapies; Small molecules
  • Mechanism of Action Alpha 1 adrenergic receptor agonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Narcolepsy
  • New Molecular Entity No

Highest Development Phases

  • Phase II Narcolepsy; Sleep disorders

Most Recent Events

  • 26 Jun 2018 The German Medicines Agency approves clinical trial application for a phase II study in patients with Excessive daytime sleepiness (EDS) related to Parkinson's disease in Germany
  • 17 Apr 2018 Phase-II clinical trials in Sleep disorders in Czech Republic (PO) (EudraCT2017-004475-31)
  • 17 Apr 2018 Phase-II clinical trials in Sleep disorders in Hungary (PO) (EudraCT2017-004475-31)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top